系列神经元特异性烯醇化酶水平与ECPR患者神经功能结局的关联:一项回顾性多中心观察性研究
这项回顾性多中心观察性研究纳入2010年5月至2016年12月接受ECPR的成人患者,两家医院将NSE测定作为ECPR方案常规部分,于ECPR后24、48、72小时系列测定NSE水平。主要终点为出院6个月时基于ECPR后48小时NSE水平的脑功能分类(CPC)量表。25例患者中,9例(36.0%)为CPC 1或2的良好神经功能结局,16例(64%)为CPC 3、4或5的不良结局。良好与不良结局组48小时NSE分别为52.1(22.3-64.9)μg/L和302.0(62.8-360.2)μg/L(p=0.01),72小时分别为37.2(12.5-53.2)μg/L和240.9(75.3-370.0)μg/L(p<0.01)。作者结论认为72小时NSE水平与ECPR后神经功能结局关联最强,48小时NSE水平亦相关。
要点
- ECPR后48小时NSE预测不良神经功能结局(CPC 3-5)的最佳截断值为140.5 μg/L,AUC 0.844(p<0.01)。
- ECPR后72小时NSE预测不良神经功能结局的最佳截断值为53.2 μg/L,AUC 0.897(p<0.01),关联最强。
- 良好结局组(CPC 1-2,n=9)与不良结局组(CPC 3-5,n=16)48小时NSE分别为52.1(22.3-64.9)μg/L vs 302.0(62.8-360.2)μg/L(p=0.01)。
- 良好与不良结局组72小时NSE分别为37.2(12.5-53.2)μg/L vs 240.9(75.3-370.0)μg/L(p<0.01)。
- 24小时NSE在良好与不良结局组分别为58.3(52.5-73.2)μg/L vs 64.2(37.9-89.8)μg/L,差异无统计学意义(p=0.95)。
适用人群与场景
- 2010年5月至2016年12月期间在两家参与医院接受ECPR的成人患者。
- 两家医院将NSE测定作为接受ECPR患者的方案常规部分,所有ECPR患者均系列测定NSE。
诊断标准与关键阈值
- 神经功能结局采用脑功能分类(CPC)量表评估:CPC 1或2为良好神经功能结局,CPC 3、4或5为不良神经功能结局。
- ECPR后48小时NSE预测不良结局的最佳截断值为140.5 μg/L(AUC 0.844,p<0.01)。
- ECPR后72小时NSE预测不良结局的最佳截断值为53.2 μg/L(AUC 0.897,p<0.01)。
研究设计与关键结果
- 研究类型为回顾性、多中心、观察性研究,纳入接受ECPR的成人患者,两家医院参与,NSE于ECPR后24、48、72小时测定,主要终点为出院6个月时基于48小时NSE水平的CPC量表。
- 出院6个月随访时,25例患者中9例(36.0%)为CPC 1或2的良好神经功能结局,16例(64%)为CPC 3、4或5的不良神经功能结局。
- 24小时NSE在良好结局组为58.3(52.5-73.2)μg/L,不良结局组为64.2(37.9-89.8)μg/L(p=0.95)。
- 48小时NSE在良好结局组为52.1(22.3-64.9)μg/L,不良结局组为302.0(62.8-360.2)μg/L(p=0.01)。
- 72小时NSE在良好结局组为37.2(12.5-53.2)μg/L,不良结局组为240.9(75.3-370.0)μg/L(p<0.01)。
- ROC曲线分析中,48小时NSE预测不良结局的最佳截断值为140.5 μg/L,AUC为0.844(p<0.01);72小时NSE最佳截断值为53.2 μg/L,AUC为0.897(p<0.01)。
证据类型、等级与局限
- 证据类型:回顾性、多中心、观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,ECPR后72小时NSE水平与神经功能结局的关联最强,48小时NSE水平亦与ECPR后神经功能结局相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM OF THE STUDY: This study aims to evaluate whether neuron-specific enolase (NSE) level at 48 h after extracorporeal cardiopulmonary resuscitation (ECPR) is associated with neurologic outcomes at 6 months after hospital discharge.
METHODS: This was a retrospective, multicenter, observational study of adult patients who received ECPR between May 2010 and December 2016. In the two hospitals involved in this study, NSE measurements were a routine part of the protocol for patients who received ECPR. Serial NSE levels were measured in all patients with ECPR. NSE levels were measured 24, 48, and 72 h after ECPR. The primary outcome was Cerebral Performance Categories (CPC) scale at 6 months after hospital discharge according to NSE levels at 48 h after ECPR.
RESULTS: At follow-up 6 months after hospital discharge, favorable neurologic outcomes of CPC 1 or 2 were observed in 9 (36.0%) of the 25 patients, and poor neurologic outcomes of CPC 3, 4, or 5 were observed in 16 (64%) patients. NSE levels at 24 h in the favorable and poor neurologic outcome groups were 58.3 (52.5-73.2) μg/L and 64.2 (37.9-89.8) μg/L, respectively (p = 0.95). NSE levels at 48 h in the favorable and poor neurologic outcome groups were 52.1 (22.3-64.9) μg/L and 302.0 (62.8-360.2) μg/L, respectively (p = 0.01). NSE levels at 72 h were 37.2 (12.5-53.2) μg/L and 240.9 (75.3-370.0) μg/L, respectively (p < 0.01). In receiver operating characteristic (ROC) curve analysis, as the predictor of poor outcome, the optimal cut-off value for NSE level at 48 h was 140.5 μg/L, and the area under the curve (AUC) was 0.844 (p < 0.01). The optimal cut-off NSE level at 72 h was 53.2 μg/L, and the AUC was 0.897 (p < 0.01).
CONCLUSIONS: NSE level at 72 h displayed the highest association with neurologic outcome after ECPR, and NSE level at 48 h was also associated with neurologic outcome after ECPR.
参考来源
- Kim HB, Yang JH, Lee YH, et al. Are serial neuron-specific enolase levels associated with neurologic outcome of ECPR patients: A retrospective multicenter observational study. Am J Emerg Med. 2023. PMID: 37060630. doi:10.1016/j.ajem.2023.03.047
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。